相关实验视频
Updated: Jun 5, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
783
经过急性血栓细胞减小后血小板的血液静止和免疫功能受损
Anita Pirabe1, Waltraud C Schrottmaier2, Dino Mehic3
1Institute of Vascular Biology and Thrombosis Research, Center of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
Journal of thrombosis and haemostasis : JTH
|December 15, 2024
概括
急性血小板缺血会损害不成熟的血小板功能,影响血液静止和免疫反应. 这凸显了了解血小板变化的必要性,以便制定更好的治疗策略.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 血栓形成的研究研究
背景情况:
- 血小板对于血管完整性,血液静止和免疫调节至关重要.
- 不成熟的血小板是最有反应的,并提供有关血栓形成的见解.
- 急性血小板缺血对不成熟血小板的功能影响尚不清楚.
研究的目的:
- 调查急性血小板缺血对新产生的不成熟血小板的功能后果.
- 为了比较小鼠模型和人类实验对象的发现.
主要方法:
- 使用大细胞或血小板枯竭和急性髓性白血病 (AML) 患者的小鼠模型.
- 在血小板上评估表面受体表达 (激活标记物,收费类受体).
- 研究了血小板形成和血小板-白细胞相互作用.
主要成果:
- 急性血小板缺血导致血液静止功能受损,并改变了小鼠不成熟血小板中的受体表达.
- 化学治疗后的AML患者表现出血小板激活,前凝功能和血小板-白细胞相互作用的减少.
- 在小鼠和人类实验对象中观察到表面受体表达的改变.
结论:
- 新产生的血小板在急性血小板缩后表现出受损的血液静止和免疫调节.
- 了解这些血小板功能变化对于优化血小板缺血症患者的治疗方法具有临床意义.
相关概念视频
Formation of the Platelet Plug
4.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.2K
Structure and Function of Platelets
980
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
980
Disorders of Hemostasis
699
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
699
Anticoagulant Drugs: Low-Molecular-Weight Heparins
608
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
608
Introduction to Hemostasis
5.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.5K
Extrinsic and Intrinsic Pathways of Hemostasis
5.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.3K

